A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV)

Vaccine

Volumn 29, Issue 49, 2011, Pages 9256-9264

  Rohde, Joerg ^a   Schirrmeier, Horst ^a   Granzow, Harald ^a   Rziha, Hanns Joachim ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Orf virus; ORFV recombinant; Parapoxvirus; Protection; Rabbit hemorrhagic disease virus (RHDV)

Indexed keywords

INACTIVATED VACCINE; INTERLEUKIN 2; LAGOVIRUS VECTOR; PROTEIN VP1; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS DNA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIVIRAL ACTIVITY; ARTICLE; CALICIVIRUS INFECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOCHEMISTRY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL RABBIT; FEMALE; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; LAGOVIRUS; LETHALITY; MALE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PLAQUE FORMING CELL; POXVIRUS; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROVOCATION TEST; RABBIT HEMORRHAGIC DISEASE; SINGLE DRUG DOSE; SOUTHERN BLOTTING; VIRUS GENE; VIRUS IMMUNITY; VIRUS ISOLATION; VIRUS LIKE AGENT; VIRUS MORPHOGENESIS; VIRUS RECOMBINANT; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CALICIVIRIDAE INFECTIONS; CERCOPITHECUS AETHIOPS; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VECTORS; HEMORRHAGIC DISEASE VIRUS, RABBIT; MALE; ORF VIRUS; RABBITS; VERO CELLS; VIRAL PLAQUE ASSAY; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 82555205236     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.121     Document Type: Article

References (58)

1. Liu S.J., Xue H.P., Quian N.H. A new viral disease in rabbits. Anim Husb Vet Med 1984, 16:253-255.
2. Mitro S., Krauss H. Rabbit hemorrhagic disease: a review with special reference to its epizootiology. Eur J Epidemiol 1993, 9(1):70-78.
3. McIntosh M.T., Behan S.C., Mohamed F.M., Lu Z., Moran K.E., Burrage T.G., et al. A pandemic strain of calicivirus threatens rabbit industries in the Americas. Virol J 2007, 4:96.
4. Green K.Y., Ando T., Balayan M.S., Berke T., Clarke I.N., Estes M.K., et al. Taxonomy of the caliciviruses. J Infect Dis 2000, 181(Suppl. 2):S322-S330.
5. Parra F., Prieto M. Purification and characterization of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits. J Virol 1990, 64(8):4013-4015.
6. Alonso C., Oviedo J.M., Martin-Alonso J.M., Diaz E., Boga J.A., Parra F. Programmed cell death in the pathogenesis of rabbit hemorrhagic disease. Arch Virol 1998, 143(2):321-332.
7. Tunon M.J., Sanchez-Campos S., Garcia-Ferreras J., Alvarez M., Jorquera F., Gonzalez-Gallego J. Rabbit hemorrhagic viral disease: characterization of a new animal model of fulminant liver failure. J Lab Clin Med 2003, 141(4):272-278.
8. Meyers G., Wirblich C., Thiel H.J. Rabbit hemorrhagic disease virus-molecular cloning and nucleotide sequencing of a calicivirus genome. Virology 1991, 184(2):664-676.
9. Meyers G., Wirblich C., Thiel H.J., Thumfart J.O. Rabbit hemorrhagic disease virus: genome organization and polyprotein processing of a calicivirus studied after transient expression of cDNA constructs. Virology 2000, 276(2):349-363.
10. Barcena J., Morales M., Vazquez B., Boga J.A., Parra F., Lucientes J., et al. Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus. J Virol 2000, 74(3):1114-1123.
11. Bertagnoli S., Gelfi J., Le G.G., Boilletot E., Vautherot J.F., Rasschaert D., et al. Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein. J Virol 1996, 70(8):5061-5066.
12. Boga J.A., Martin Alonso J.M., Casais R., Parra F. A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection. J Gen Virol 1997, 78(Pt. 9):2315-2318.
13. Castanon S., Marin M.S., Martin-Alonso J.M., Boga J.A., Casais R., Humara J.M., et al. Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus. J Virol 1999, 73(5):4452-4455.
14. Fernandez-Fernandez M.R., Mourino M., Rivera J., Rodriguez F., Plana-Duran J., Garcia J.A. Protection of rabbits against rabbit hemorrhagic disease virus by immunization with the VP60 protein expressed in plants with a potyvirus-based vector. Virology 2001, 280(2):283-291.
15. Fischer L., Le Gros F.X., Mason P.W., Paoletti E. A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge. Vaccine 1997, 15(1):90-96.
16. Gil F., Titarenko E., Terrada E., Arcalis E., Escribano J.M. Successful oral prime-immunization with VP60 from rabbit haemorrhagic disease virus produced in transgenic plants using different fusion strategies. Plant Biotechnol J 2006, 4(1):135-143.
17. Marin M.S., Martin Alonso J.M., Perez Ordoyo Garcia L.I., Boga J.A., rguello-Villares J.L., Casais R., et al. Immunogenic properties of rabbit haemorrhagic disease virus structural protein VP60 expressed by a recombinant baculovirus: an efficient vaccine. Virus Res 1995, 39(2-3):119-128.
18. Mikschofsky H., Schirrmeier H., Keil G.M., Lange B., Polowick P.L., Keller W., et al. Pea-derived vaccines demonstrate high immunogenicity and protection in rabbits against rabbit haemorrhagic disease virus. Plant Biotechnol J 2009, 7(6):537-549.
19. Perez-Filgueira D.M., Resino-Talavan P., Cubillos C., Angulo I., Barderas M.G., Barcena J., et al. Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV. Virology 2007, 364(2):422-430.
20. Torres J.M., Sanchez C., Ramirez M.A., Morales M., Barcena J., Ferrer J., et al. First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease. Vaccine 2001, 19(31):4536-4543.
21. Gromadzka B., Szewczyk B., Konopa G., Fitzner A., Kesy A. Recombinant VP60 in the form of virion-like particles as a potential vaccine against rabbit hemorrhagic disease virus. Acta Biochim Pol 2006, 53(2):371-376.
22. Laurent S., Vautherot J.F., Madelaine M.F., Le G.G., Rasschaert D. Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. J Virol 1994, 68(10):6794-6798.
23. Nagesha H.S., Wang L.F., Hyatt A.D. Virus-like particles of calicivirus as epitope carriers. Arch Virol 1999, 144(12):2429-2439.
24. Nagesha H.S., Wang L.F., Hyatt A.D., Morrissy C.J., Lenghaus C., Westbury H.A. Self-assembly, antigenicity, and immunogenicity of the rabbit haemorrhagic disease virus (Czechoslovakian strain V-351) capsid protein expressed in baculovirus. Arch Virol 1995, 140(6):1095-1108.
25. Peacey M., Wilson S., Baird M.A., Ward V.K. Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation. Biotechnol Bioeng 2007, 98(5):968-977.
26. Peacey M., Wilson S., Perret R., Ronchese F., Ward V.K., Young V., et al. Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response. Vaccine 2008, 26(42):5334-5337.
27. Plana-Duran J., Bastons M., Rodriguez M.J., Climent I., Cortes E., Vela C., et al. Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic disease. Arch Virol 1996, 141(8):1423-1436.
28. Young S.L., Wilson M., Wilson S., Beagley K.W., Ward V., Baird M.A. Transcutaneous vaccination with virus-like particles. Vaccine 2006, 24(26):5406-5412.
29. Brun A., Albina E., Barret T., Chapman D.A., Czub M., Dixon L.K., et al. Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems. Vaccine 2008, 26(51):6508-6528.
30. Friebe A., Friederichs S., Scholz K., Janssen U., Scholz C., Schlapp T., et al. Characterization of immunostimulatory components of orf virus (parapoxvirus ovis). J Gen Virol 2011, 92(Pt. 7 (July)):1571-1584.
31. Rziha H.J., Henkel M., Cottone R., Bauer B., Auge U., Goetz F., et al. Generation of recombinant parapoxviruses: non-essential genes suitable for insertion and expression of foreign genes. J Biotechnol 2000, 83:137-145.
32. Buettner M., Rziha H.J. Parapoxviruses: from the lesion to the viral genome. J Vet Med B: Infect Dis Vet Public Health 2002, 49(1):7-16.
33. Haig D.M. Orf virus infection and host immunity. Curr Opin Infect Dis 2006, 19(2):127-131.
34. Siegemund S., Hartl A., von B.H., Dautel F., Raue R., Freudenberg M.A., et al. Conventional bone marrow-derived dendritic cells contribute to toll-like receptor-independent production of alpha/beta interferon in response to inactivated parapoxvirus ovis. J Virol 2009, 83(18):9411-9422.
35. Hosamani M., Scagliarini A., Bhanuprakash V., McInnes C.J., Singh R.K. Orf: an update on current research and future perspectives. Expert Rev Anti Infect Ther 2009, 7(7):879-893.
36. Fischer T., Planz O., Stitz L., Rziha H.J. Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice. J Virol 2003, 77(17):9312-9323.
37. Henkel M., Planz O., Fischer T., Stitz L., Rziha H.J. Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant. J Virol 2005, 79(1):314-325.
38. Voigt H., Merant C., Wienhold D., Braun A., Hutet E., Le Potier M.F., et al. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2). Vaccine 2007, 25(31):5915-5926.
39. Schirrmeier H., Reimann I., Kollner B., Granzow H. Pathogenic, antigenic and molecular properties of rabbit haemorrhagic disease virus (RHDV) isolated from vaccinated rabbits: detection and characterization of antigenic variants. Arch Virol 1999, 144(4):719-735.
40. Wirblich C., Meyers G., Ohlinger V.F., Capucci L., Eskens U., Haas B., et al. European brown hare syndrome virus: relationship to rabbit hemorrhagic disease virus and other caliciviruses. J Virol 1994, 68(8):5164-5173.
41. Pasamontes L., Gubser J., Wittek R., Viljoen G.J. Direct identification of recombinant vaccinia virus plaques by PCR. J Virol Methods 1991, 35(2):137-141.
42. Carlemalm E., Garavito R.M., Villiger W. Resin development for electron microscopy and an analysis of embedding at low temperature. J Microstruct 1982, 126:123-143.
43. Gall A., Hoffmann B., Teifke J.P., Lange B., Schirrmeier H. Persistence of viral RNA in rabbits which overcome an experimental RHDV infection detected by a highly sensitive multiplex real-time RT-PCR. Vet Microbiol 2007, 120(1-2):17-32.
44. Yuen L., Moss B. Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes. Proc Natl Acad Sci USA 1987, 84(18):6417-6421.
45. Nerenberg B.T., Taylor J., Bartee E., Gouveia K., Barry M., Fruh K. The poxviral RING protein p28 is a ubiquitin ligase that targets ubiquitin to viral replication factories. J Virol 2005, 79(1):597-601.
46. Resch W., Weisberg A.S., Moss B. Vaccinia virus nonstructural protein encoded by the A11R gene is required for formation of the virion membrane. J Virol 2005, 79(11):6598-6609.
47. Roberts K.L., Smith G.L. Vaccinia virus morphogenesis and dissemination. Trends Microbiol 2008, 16(10):472-479.
48. Cheetham S., Souza M., Meulia T., Grimes S., Han M.G., Saif L.J. Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J Virol 2006, 80(21):10372-10381.
49. Flynn W.T., Saif L.J. Serial propagation of porcine enteric calicivirus-like virus in primary porcine kidney cell cultures. J Clin Microbiol 1988, 26(2):206-212.
50. Dory D., Fischer T., Beven V., Cariolet R., Rziha H.J., Jestin A. Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1). Vaccine 2006.
51. Bertagnoli S., Gelfi J., Petit F., Vautherot J.F., Rasschaert D., Laurent S., et al. Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus. Vaccine 1996, 14(6):506-510.
52. Boga J.A., Casais R., Marin M.S., Martin-Alonso J.M., Carmenes R.S., Prieto M., et al. Molecular cloning, sequencing and expression in Escherichia coli of the capsid protein gene from rabbit haemorrhagic disease virus (Spanish isolate AST/89). J Gen Virol 1994, 75(Pt. 9):2409-2413.
53. Chasey D., Lucas M.H., Westcott D.G., Sharp G., Kitching A., Hughes S.K. Development of a diagnostic approach to the identification of rabbit haemorrhagic disease. Vet Rec 1995, 137(7):158-160.
54. Ferreira P.G., Dinis M., Costa E.S., Aguas A.P. Adult rabbits acquire resistance to lethal calicivirus infection by adoptive transfer of sera from infected young rabbits. Vet Immunol Immunopathol 2008, 121(3-4):364-369.
55. Capucci L., Frigoli G., Ronshold L., Lavazza A., Brocchi E., Rossi C. Antigenicity of the rabbit hemorrhagic disease virus studied by its reactivity with monoclonal antibodies. Virus Res 1995, 37(3):221-238.
56. Lindesmith L., Moe C., Lependu J., Frelinger J.A., Treanor J., Baric R.S. Cellular and humoral immunity following Snow Mountain virus challenge. J Virol 2005, 79(March (5)):2900-2909.
57. Bachmann M.F., Oxenius A. Interleukin 2: from immunostimulation to immunoregulation and back again. EMBO Rep 2007, 8(December (12)):1142-1148.
58. Friebe A., Siegling A., Friederichs S., Volk H.D., Weber O. Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells. J Virol 2004, 78(Sepetmber (17)):9400-9411.